MAPT and Cognitive impairment: To investigate the role of CCH in AD-related brain abnormalities and cognitive impairment, we performed UCCAO in adult mice and then studied general and memory behavior, O-GlcNAcylation, tau phosphorylation, synaptic proteins, hexosamine biosynthetic pathway (HBP) and insulin signaling.